249 related articles for article (PubMed ID: 32253807)
1. Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering.
Joo JI; Choi M; Jang SH; Choi S; Park SM; Shin D; Cho KH
Adv Mater; 2020 Sep; 32(35):e1906783. PubMed ID: 32253807
[TBL] [Abstract][Full Text] [Related]
2. Future of personalized medicine in oncology: a systems biology approach.
Gonzalez-Angulo AM; Hennessy BT; Mills GB
J Clin Oncol; 2010 Jun; 28(16):2777-83. PubMed ID: 20406928
[TBL] [Abstract][Full Text] [Related]
3. Cancer Systems Biology: a peek into the future of patient care?
Werner HM; Mills GB; Ram PT
Nat Rev Clin Oncol; 2014 Mar; 11(3):167-76. PubMed ID: 24492837
[TBL] [Abstract][Full Text] [Related]
4. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
[TBL] [Abstract][Full Text] [Related]
5. Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P; Cabral H; Kataoka K
Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
[TBL] [Abstract][Full Text] [Related]
6. Theranostic applications of peptide-based nanoformulations for growth factor defective cancers.
Ghosh A; Maske P; Patel V; Dubey J; Aniket K; Srivastava R
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129151. PubMed ID: 38181914
[TBL] [Abstract][Full Text] [Related]
7. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
8. Navigating cancer network attractors for tumor-specific therapy.
Creixell P; Schoof EM; Erler JT; Linding R
Nat Biotechnol; 2012 Sep; 30(9):842-8. PubMed ID: 22965061
[TBL] [Abstract][Full Text] [Related]
9. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
Verkhivker GM
Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
[TBL] [